BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 238 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2020. The put-call ratio across all filers is 0.71 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,620,982 | -13.9% | 52,190 | +8.4% | 0.00% | 0.0% |
| Q2 2023 | $3,042,764 | +18.7% | 48,145 | -15.5% | 0.00% | 0.0% |
| Q1 2023 | $2,564,025 | -8.0% | 56,991 | -10.4% | 0.00% | 0.0% |
| Q4 2022 | $2,786,000 | -34.9% | 63,589 | -2.1% | 0.00% | -50.0% |
| Q3 2022 | $4,282,000 | +16.2% | 64,972 | -11.0% | 0.00% | +100.0% |
| Q2 2022 | $3,686,000 | -18.4% | 73,002 | +3.2% | 0.00% | 0.0% |
| Q1 2022 | $4,519,000 | -15.1% | 70,735 | +42.3% | 0.00% | 0.0% |
| Q4 2021 | $5,324,000 | +10.4% | 49,706 | +6.0% | 0.00% | -50.0% |
| Q3 2021 | $4,822,000 | +24.0% | 46,901 | +6.1% | 0.00% | +100.0% |
| Q2 2021 | $3,890,000 | -3.8% | 44,222 | +6.3% | 0.00% | 0.0% |
| Q1 2021 | $4,044,000 | -24.5% | 41,594 | -12.9% | 0.00% | -50.0% |
| Q4 2020 | $5,358,000 | +12.1% | 47,764 | -7.4% | 0.00% | 0.0% |
| Q3 2020 | $4,780,000 | +0.2% | 51,568 | -15.7% | 0.00% | 0.0% |
| Q2 2020 | $4,770,000 | +10.3% | 61,142 | -17.3% | 0.00% | 0.0% |
| Q1 2020 | $4,326,000 | +120.2% | 73,948 | +201.3% | 0.00% | +100.0% |
| Q4 2019 | $1,965,000 | -19.9% | 24,543 | -26.5% | 0.00% | 0.0% |
| Q3 2019 | $2,453,000 | -60.2% | 33,385 | -48.9% | 0.00% | -66.7% |
| Q2 2019 | $6,166,000 | +19.8% | 65,377 | +1.7% | 0.00% | +50.0% |
| Q1 2019 | $5,146,000 | +2167.0% | 64,294 | +1425.4% | 0.00% | – |
| Q4 2018 | $227,000 | -87.9% | 4,215 | -85.7% | 0.00% | -100.0% |
| Q2 2018 | $1,869,000 | -67.5% | 29,454 | -53.0% | 0.00% | -66.7% |
| Q1 2018 | $5,751,000 | +9.4% | 62,718 | -10.1% | 0.00% | +50.0% |
| Q4 2017 | $5,259,000 | +39.2% | 69,757 | +28.6% | 0.00% | 0.0% |
| Q3 2017 | $3,779,000 | +345.1% | 54,258 | +15.4% | 0.00% | +100.0% |
| Q1 2016 | $849,000 | -71.2% | 47,014 | -57.9% | 0.00% | -50.0% |
| Q4 2015 | $2,943,000 | +56.3% | 111,752 | +26.1% | 0.00% | +100.0% |
| Q3 2015 | $1,883,000 | -63.7% | 88,607 | -54.8% | 0.00% | -66.7% |
| Q2 2015 | $5,194,000 | – | 196,096 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 645,539 | $69,144,000 | 7.84% |
| DAFNA Capital Management LLC | 206,911 | $22,162,000 | 5.57% |
| Eagle Health Investments LP | 192,639 | $20,634,000 | 5.03% |
| Casdin Capital, LLC | 1,550,000 | $166,021,000 | 4.68% |
| CADIAN CAPITAL MANAGEMENT, LP | 450,657 | $48,270,000 | 2.65% |
| Avidity Partners Management LP | 995,000 | $106,574,000 | 2.26% |
| Integral Health Asset Management, LLC | 75,000 | $8,033,000 | 2.22% |
| Rock Springs Capital Management LP | 859,755 | $92,088,000 | 2.13% |
| Boxer Capital, LLC | 507,374 | $54,345,000 | 2.11% |
| EFG Asset Management (North America) Corp. | 112,715 | $12,082,000 | 1.58% |